An Open Label Trial to Investigate Macugen for the Preservation of Visual Function in Subjects With Neovascular AMD

Clinical trial NCT00327470 · TERMINATED

Trial details

NCT number: NCT00327470
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Age Related Macular Degeneration (AMD)Macular Degeneration Choroidal Neovascularization (CNV)

Start date: 2006-07-01
Primary completion: 2009-08-01
Enrollment: 288

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.